Difference between revisions of "Main Page"

From HemOnc.org - A Hematology Oncology Wiki
Jump to navigation Jump to search
Line 24: Line 24:
 
|style="background-color:#F0F8FF"|[[Breast cancer]]
 
|style="background-color:#F0F8FF"|[[Breast cancer]]
 
|-
 
|-
 +
|style="background-color:#F0F8FF"|[[Breast cancer, HER-2 positive]]
 
|style="background-color:#F0F8FF"|[[Central nervous system (CNS) cancer]]
 
|style="background-color:#F0F8FF"|[[Central nervous system (CNS) cancer]]
 
|style="background-color:#F0F8FF"|[[Cervical cancer]]
 
|style="background-color:#F0F8FF"|[[Cervical cancer]]
 
|style="background-color:#F0F8FF"|[[Colon cancer]]
 
|style="background-color:#F0F8FF"|[[Colon cancer]]
 +
|-
 
|style="background-color:#F0F8FF"|[[Esophageal cancer]]
 
|style="background-color:#F0F8FF"|[[Esophageal cancer]]
−
|-
 
 
|style="background-color:#F0F8FF"|[[Ewing's sarcoma]]
 
|style="background-color:#F0F8FF"|[[Ewing's sarcoma]]
 
|style="background-color:#F0F8FF"|[[Gastric cancer]]
 
|style="background-color:#F0F8FF"|[[Gastric cancer]]
 
|style="background-color:#F0F8FF"|[[Germ cell tumors]]
 
|style="background-color:#F0F8FF"|[[Germ cell tumors]]
 +
|-
 
|style="background-color:#F0F8FF"|[[Head and neck cancer]]
 
|style="background-color:#F0F8FF"|[[Head and neck cancer]]
−
|-
 
 
|style="background-color:#F0F8FF"|[[Hepatobiliary cancer]]
 
|style="background-color:#F0F8FF"|[[Hepatobiliary cancer]]
 
|style="background-color:#F0F8FF"|[[Non-small cell lung cancer | Lung cancer, non-small cell]]
 
|style="background-color:#F0F8FF"|[[Non-small cell lung cancer | Lung cancer, non-small cell]]
 
|style="background-color:#F0F8FF"|[[Small cell lung cancer | Lung cancer, small cell]]
 
|style="background-color:#F0F8FF"|[[Small cell lung cancer | Lung cancer, small cell]]
 +
|-
 
|style="background-color:#F0F8FF"|[[Melanoma]]  
 
|style="background-color:#F0F8FF"|[[Melanoma]]  
−
|-
 
 
|style="background-color:#F0F8FF"|[[Merkel cell carcinoma]]  
 
|style="background-color:#F0F8FF"|[[Merkel cell carcinoma]]  
 
|style="background-color:#F0F8FF"|[[Mesothelioma]]
 
|style="background-color:#F0F8FF"|[[Mesothelioma]]
 
|style="background-color:#F0F8FF"|[[Neuroblastoma]]
 
|style="background-color:#F0F8FF"|[[Neuroblastoma]]
 +
|-
 
|style="background-color:#F0F8FF"|[[Neuroendocrine tumors]]
 
|style="background-color:#F0F8FF"|[[Neuroendocrine tumors]]
−
|-
 
 
|style="background-color:#F0F8FF"|[[Osteosarcoma]]
 
|style="background-color:#F0F8FF"|[[Osteosarcoma]]
 
|style="background-color:#F0F8FF"|[[Ovarian cancer]]
 
|style="background-color:#F0F8FF"|[[Ovarian cancer]]
 
|style="background-color:#F0F8FF"|[[Pancreatic cancer]]  
 
|style="background-color:#F0F8FF"|[[Pancreatic cancer]]  
 +
|-
 
|style="background-color:#F0F8FF"|[[Penile cancer]]
 
|style="background-color:#F0F8FF"|[[Penile cancer]]
−
|-
 
 
|style="background-color:#F0F8FF"|[[Prostate cancer]]
 
|style="background-color:#F0F8FF"|[[Prostate cancer]]
 
|style="background-color:#F0F8FF"|[[Rectal cancer]]
 
|style="background-color:#F0F8FF"|[[Rectal cancer]]
 
|style="background-color:#F0F8FF"|[[Renal cancer]]
 
|style="background-color:#F0F8FF"|[[Renal cancer]]
 +
|-
 
|style="background-color:#F0F8FF"|[[Sarcoma]]  
 
|style="background-color:#F0F8FF"|[[Sarcoma]]  
−
|-
 
 
|style="background-color:#F0F8FF"|[[Basal cell and squamous cell skin cancer | Skin, basal & squamous cancer]]
 
|style="background-color:#F0F8FF"|[[Basal cell and squamous cell skin cancer | Skin, basal & squamous cancer]]
 
|style="background-color:#F0F8FF"|[[Testicular cancer]]
 
|style="background-color:#F0F8FF"|[[Testicular cancer]]
 
|style="background-color:#F0F8FF"|[[Thymoma]]
 
|style="background-color:#F0F8FF"|[[Thymoma]]
 +
|-
 
|style="background-color:#F0F8FF"|[[Thyroid cancer]]
 
|style="background-color:#F0F8FF"|[[Thyroid cancer]]
−
|-
 
 
|style="background-color:#F0F8FF"|[[Unknown primary]]  
 
|style="background-color:#F0F8FF"|[[Unknown primary]]  
 
|style="background-color:#F0F8FF"|[[Uterine cancer]]
 
|style="background-color:#F0F8FF"|[[Uterine cancer]]
−
|style="background-color:#F0F8FF"|
 
 
|style="background-color:#F0F8FF"|
 
|style="background-color:#F0F8FF"|
 
|-
 
|-

Revision as of 19:18, 30 January 2017

HemOnc.org - A Free Hematology/Oncology Reference

4,428 regimens on HemOnc.org
6,546 variants on HemOnc.org

Created as a knowledge base for hematology & oncology providers, HemOnc.org is a collaborative wiki containing details about 100s of hematology/oncology drugs, and 1000s of antineoplastic regimens. Content is added by hematology & oncology providers, and undergoes continuous peer review.

If this is your first time visiting, please go to the tutorial page or just start exploring!
Desktop Version of HemOnc.org | Mobile (phone/tablet) Version of HemOnc.org
How to add a HemOnc.org shortcut to your mobile device's home screen
Quick links to chemotherapy regimens
Solid tumors
Anal cancer Bladder cancer Bone cancer Breast cancer
Breast cancer, HER-2 positive Central nervous system (CNS) cancer Cervical cancer Colon cancer
Esophageal cancer Ewing's sarcoma Gastric cancer Germ cell tumors
Head and neck cancer Hepatobiliary cancer Lung cancer, non-small cell Lung cancer, small cell
Melanoma Merkel cell carcinoma Mesothelioma Neuroblastoma
Neuroendocrine tumors Osteosarcoma Ovarian cancer Pancreatic cancer
Penile cancer Prostate cancer Rectal cancer Renal cancer
Sarcoma Skin, basal & squamous cancer Testicular cancer Thymoma
Thyroid cancer Unknown primary Uterine cancer
Acute leukemias
Acute myeloid leukemia (AML) Acute promyelocytic leukemia (APL) B-cell acute lymphoblastic leukemia (B-ALL) T-cell acute lymphoblastic leukemia/lymphoma (T-ALL/T-LBL)
CNS leukemia Transplant conditioning regimens
Myeloproliferative neoplasms and myelodysplastic syndromes
Chronic myelogenous leukemia (CML) Chronic myelomonocytic leukemia (CMML) Essential thrombocythemia (ET) Hypereosinophilic syndrome (HES)
Myelodysplastic syndrome Primary & secondary myelofibrosis Polycythemia vera (PV) Systemic mastocytosis
Mature B-, T-, and NK-cell neoplasms
Adult T-cell leukemia-lymphoma (ATLL) Anaplastic large cell lymphoma (ALCL) Burkitt lymphoma (BL) or Burkitt-like lymphoma Chronic lymphocytic leukemia (CLL/SLL)
CNS lymphoma Cutaneous T-cell lymphoma (CTCL) Diffuse large B-cell lymphoma (DLBCL) Extranodal NK/T-cell lymphoma, nasal type
Follicular lymphoma (FL) Hairy cell leukemia (HCL) HIV-associated lymphoma Hodgkin lymphoma (HL)
Hodgkin lymphoma, nodular lymphocyte-predominant (NLP-HL) Large granular lymphocytic (LGL) leukemia Light-chain (AL) amyloidosis Mantle cell lymphoma (MCL)
Marginal zone lymphoma (MZL) Mediastinal gray-zone lymphoma (MGZL) Multiple myeloma (MM) NK/T-cell lymphoma
Peripheral T-cell Lymphoma (PTCL) Plasma cell leukemia Primary mediastinal B-cell lymphoma (PMBL) Transformed lymphoma (TL)
Transplant conditioning regimens Waldenström macroglobulinemia (WM/LPL)
Other hematology
Aplastic anemia Atypical hemolytic-uremic syndrome (aHUS) Autoimmune cytopenias Autoimmune thrombocytopenic purpura (ITP)
Castleman’s disease Coagulopathies Cold agglutinin disease Hemophagocytic lymphohistiocytosis (HLH)
Histiocytoses Paroxysmal nocturnal hemoglobinuria (PNH) Sickle cell anemia Thrombotic thrombocytopenic purpura (TTP)
Venous thromboembolism (VTE)
Browse our complete index of pages


Any information that one feels would be helpful to other oncology providers is welcome. Visit how to contribute for more details. Priorities of this project include:

  1. Creating a database of chemotherapy agents and other medications.
  2. Creating a database of chemotherapy regimens and references to primary literature (PubMed and direct links to the abstracts/full articles).
  3. Sample order sets and examples of supportive medications used with treatment regimens
  4. Aggregating useful links to existing resources by disease, such as information about prognosis, clinical calculators, staging, and patient resources.

Additional possibilities for this project may include:

  1. Creating summaries of pivotal clinical trials
  2. Establishing homepages for ongoing clinical trials that contain information and sites of participation
  3. Checklists for common clinical scenarios/diseases
  4. Creating checklists that can be used for patients starting therapy with particular regimens, such as laboratory & imaging (e.g. echocardiogram, PFTs) parameters to monitor and informed consent/discussion of side effects

The field of hematology/oncology is ever-changing, and our hope is that other people will be interested in contributing to make it an increasingly more useful resource. The rapidly evolving nature of the practice demands a more dynamic medium than existing resources can provide and would benefit from being able to be updated in real-time from virtually any computer with internet access. We believe that the familiar format of a Wiki, made popular by sites such as Wikipedia, will significantly help ease-of-use and navigation.

If you would like to contribute, please create an account in the upper right corner, and send a message to [email protected] so that your account can be set up with the necessary rights. Due to the sensitive nature of the information contained within this site, unverified users will not be allowed to edit articles.

Retrieved from "https://hemonc.org/w/index.php?title=Main_Page&oldid=13050"